Surgical Outcomes of Lobular Neoplasia Diagnosed in Core Biopsy: Prospective Study of 316 Cases.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Clinical Breast Cancer

• Publication date

  2016-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.clbc.2016.06.003PMID 27425222
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Incidence of Adjacent Synchronous Invasive Carcinoma and/or Ductal Carcinoma In-situ in Patients with Lobular Neoplasia on Core Biopsy: Results from a Prospective Multi-Institutional Registry (TBCRC 020)

  2016cited by this paper
• Gene expression profiling of lobular carcinoma in situ reveals candidate precursor genes for invasion

  2015cited by this paper
• Atypical hyperplasia of the breast--risk assessment and management options.

  2015cited by this paper
• Lobular neoplasia.

  2014cited by this paper
• A systematic review of surgical biopsy for LCIS found at core needle biopsy - do we have the answer yet?

  2014cited by this paper
• Understanding the Premalignant Potential of Atypical Hyperplasia through Its Natural History: A Longitudinal Cohort Study

  2014cited by this paper
• Pathologic upgrade rates on subsequent excision when lobular carcinoma in situ is the primary diagnosis in the needle core biopsy with special attention to the radiographic target.

  2013cited by this paper
• Classic lobular carcinoma in situ and atypical lobular hyperplasia at percutaneous breast core biopsy

  2013cited by this paper
• Histologic work-up of non-palpable breast lesions classified as probably benign at initial mammography and/or ultrasound (BI-RADS category 3).

  2013cited by this paper
• Classic lobular neoplasia on core biopsy: a clinical and radio-pathologic correlation study with follow-up excision biopsy

  2013cited by this paper
• Current management practice of breast borderline lesions--need for further research and guidelines.

  2012cited by this paper
• Lobular In-Situ Neoplasia on Breast Core Needle Biopsy: Imaging Indication and Pathologic Extent Can Identify Which Patients Require Excisional Biopsy

  2012cited by this paper
• Surgical outcome of biopsy-proven lobular neoplasia: is there any difference between lobular carcinoma in situ and atypical lobular hyperplasia?

  2012cited by this paper
• Low frequency of cancer occurrence in same breast quadrant diagnosed with lobular neoplasia at percutaneous needle biopsy.

  2012cited by this paper
• Variations in physician recommendations for surgery after diagnosis of a high-risk lesion on breast core needle biopsy.

  2012cited by this paper
• The role of chemoprevention in modifying the risk of breast cancer in women with atypical breast lesions

  2012cited by this paper
• The low nuclear grade breast neoplasia family

  2012cited by this paper
• Breast cancer precursors revisited: molecular features and progression pathways

  2010cited by this paper
• Screen‐detected pleomorphic lobular carcinoma in situ (PLCIS): risk of concurrent invasive malignancy following a core biopsy diagnosis

  2010cited by this paper
• Lobular carcinoma in situ variants in breast cores: potential for misdiagnosis, upgrade rates at surgical excision, and practical implications.

  2010cited by this paper
• Where's the outrage?

  2009cited by this paper
• Lobular neoplasia on core needle biopsy does not require excision

  2008cited by this paper
• Pleomorphic Lobular Carcinoma In Situ (PLCIS) on Breast Core Needle Biopsies: Clinical Significance and Immunoprofile

  2008cited by this paper
• Atypical lobular hyperplasia and classic lobular carcinoma in situ in core biopsy specimens: routine excision is not necessary

  2008cited by this paper
• Lobular neoplasia at percutaneous breast biopsy: variables associated with carcinoma at surgical excision.

  2008cited by this paper
• The probably benign assessment.

  2007cited by this paper
• High Frequency of Coexistence of Columnar Cell Lesions, Lobular Neoplasia, and Low Grade Ductal Carcinoma In Situ With Invasive Tubular Carcinoma and Invasive Lobular Carcinoma

  2007cited by this paper
• Magnitude and laterality of breast cancer risk according to histologic type of atypical hyperplasia

  2007cited by this paper
• Stratification of breast cancer risk in women with atypia: a Mayo cohort study.

  2007cited by this paper
• Lobular Intraepithelial Neoplasia [Lobular Carcinoma In Situ] With Comedo-type Necrosis: A Clinicopathologic Study of 18 Cases

  2006cited by this paper
• Genomic alterations in lobular neoplasia: A microarray comparative genomic hybridization signature for early neoplastic proliferationin the breast

  2006cited by this paper
• Clonality of lobular carcinoma in situ and synchronous invasive lobular carcinoma

  2004cited by this paper
• Cancer upgrades at excisional biopsy after diagnosis of atypical lobular hyperplasia or lobular carcinoma in situ at core-needle biopsy: some reasons why.

  2004cited by this paper
• Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study.

  2003cited by this paper
• Changing Incidence of Lobular Carcinoma in situ of the Breast

  2002cited by this paper
• Clinical, Histopathologic, and Biologic Features of Pleomorphic Lobular (Ductal-Lobular) Carcinoma In Situ of the Breast: A Report of 24 Cases

  2002cited by this paper
• Calcifications of lobular carcinoma in situ of the breast: radiologic-pathologic correlation.

  2001cited by this paper
• Imaging-histologic discordance at percutaneous breast biopsy.

  2000cited by this paper
• Imaging–histologic discordance at percutaneous breast biopsy

  2000cited by this paper
• Comparative genomic hybridization analysis of lobular carcinoma in situ and atypical lobular hyperplasia and potential roles for gains and losses of genetic material in breast neoplasia.

  1998cited by this paper
• Reproducibility and validity of pathologi classifications of benign breast disease and implications for clinical applications

  1993cited by this paper
• Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease.

  1991cited by this paper
• Atypical hyperplastic lesions of the female breast. A long‐term follow‐up study

  1985cited by this paper
• Lobular carcinoma in situ of the breast Detailed analysis of 99 patients with average follow‐up of 24 years

  1978cited by this paper
• Lobular neoplasia (so‐called lobular carcinoma in situ) of the breast

  1978cited by this paper

• Pleomorphic and florid lobular carcinoma in situ of the Breast: A systematic review of current evidence and knowledge gaps

  2026cites this paper
• Clinicopathological features of microinvasive lobular carcinoma

  2025cites this paper
• Breast Cancer Polygenic Risk Score Associated with Outcomes after In Situ Breast Disease

  2025cites this paper
• Long-term follow-up confirms patients with high-risk breast lesions can be successfully managed at a multidisciplinary conferences

  2025cites this paper
• Immediate and ipsilateral recurrence rates and treatment recommendations for patients with pleomorphic and florid lobular carcinoma in situ

  2025cites this paper
• Consensus document on preoperative diagnostic procedures in breast lesions

  2025cites this paper
• Atypical ductal or lobular hyperplasia, lobular carcinoma in-situ, flat epithelial atypia, and future risk of developing breast cancer: Systematic review and meta-analysis

  2024cites this paper
• "Lobular lesions of the breast: From the classic to the variants".

  2024cites this paper
• Engaging Multidisciplinary Teams to Develop Pragmatic Clinical Practice Guidelines to Support Management of Patients With High-Risk Breast Lesions.

  2024cites this paper
• Upgrade rates of variant lobular carcinoma in-situ (LCIS) compared to classic LCIS diagnosed in core needle biopsies: A ten-year single institution retrospective study.

  2024cites this paper
• than 30 years

  2022cites this paper
• The morphologic spectrum of lobular carcinoma in situ (LCIS) observations on clinical significance, management implications and diagnostic pitfalls of classic, florid and pleomorphic LCIS

  2022cites this paper
• Risk of Lobular Neoplasia Upgrade with Synchronous Carcinoma

  2022cites this paper
• Lobular Neoplasia.

  2022cites this paper
• ACR Appropriateness Criteria® Imaging After Breast Surgery.

  2022cites this paper
• than 30 years

  2022cites this paper
• Current Perspectives on Lobular Neoplasia of the Breast

  2022cites this paper
• Variant 3: Adult female younger than 30 years of age. Postsurgical excision with nonmalignant pathology. Asymptomatic. Initial imaging.

  2022cites this paper
• Variant 3: Adult female younger than 30 years of age. Postsurgical excision with nonmalignant pathology. Asymptomatic. Initial imaging.

  2022cites this paper
• Variant 3: Adult female younger than 30 years of age. Postsurgical excision with nonmalignant pathology. Asymptomatic. Initial imaging.

  2022cites this paper
• Variant 3: Adult female younger than 30 years of age. Postsurgical excision with nonmalignant pathology. Asymptomatic. Initial imaging.

  2022cites this paper
• Variant 3: Adult female younger than 30 years of age. Postsurgical excision with nonmalignant pathology. Asymptomatic. Initial imaging.

  2022cites this paper
• Variant 3: Adult female younger than 30 years of age. Postsurgical excision with nonmalignant pathology. Asymptomatic. Initial imaging.

  2022cites this paper
• than 30 years

  2022cites this paper
• Variant 3: Adult female younger than 30 years of age. Postsurgical excision with nonmalignant pathology. Asymptomatic. Initial imaging.

  2022cites this paper
• Variant 3: Adult female younger than 30 years of age. Postsurgical excision with nonmalignant pathology. Asymptomatic. Initial imaging.

  2022cites this paper
• than 30 years

  2022cites this paper
• Variant 3: Adult female younger than 30 years of age. Postsurgical excision with nonmalignant pathology. Asymptomatic. Initial imaging.

  2022cites this paper
• Variant 3: Adult female younger than 30 years of age. Postsurgical excision with nonmalignant pathology. Asymptomatic. Initial imaging.

  2022cites this paper
• Variant 3: Adult female younger than 30 years of age. Postsurgical excision with nonmalignant pathology. Asymptomatic. Initial imaging.

  2022cites this paper
• than 30 years

  2022cites this paper
• than 30 years

  2022cites this paper
• Variant 3: Adult female younger than 30 years of age. Postsurgical excision with nonmalignant pathology. Asymptomatic. Initial imaging.

  2022cites this paper
• than 30 years

  2022cites this paper
• Variant 3: Adult female younger than 30 years of age. Postsurgical excision with nonmalignant pathology. Asymptomatic. Initial imaging.

  2022cites this paper
• Variant 3: Adult female younger than 30 years of age. Postsurgical excision with nonmalignant pathology. Asymptomatic. Initial imaging.

  2022cites this paper
• than 30 years

  2022cites this paper
• Variant 3: Adult female younger than 30 years of age. Postsurgical excision with nonmalignant pathology. Asymptomatic. Initial imaging.

  2022cites this paper
• Variant 3: Adult female younger than 30 years of age. Postsurgical excision with nonmalignant pathology. Asymptomatic. Initial imaging.

  2022cites this paper
• Variant 3: Adult female younger than 30 years of age. Postsurgical excision with nonmalignant pathology. Asymptomatic. Initial imaging.

  2022cites this paper
• than 30 years

  2022cites this paper
• than 30 years

  2022cites this paper
• than 30 years

  2022cites this paper
• than 30 years

  2022cites this paper
• than 30 years

  2022cites this paper
• than 30 years

  2022cites this paper
• Variant 3: Adult female younger than 30 years of age. Postsurgical excision with nonmalignant pathology. Asymptomatic. Initial imaging.

  2022cites this paper
• Morphologic subtypes of lobular carcinoma in situ diagnosed on core needle biopsy: clinicopathologic features and findings at follow-up excision

  2021cites this paper
• Upgrade Rates of Pure, Radiology-Pathology Concordant Lobular Neoplasia Diagnosed on Breast Core Needle Biopsy: Is Surgical Excision Warranted?

  2021cites this paper
• High-Risk Lesions Detected by MRI-Guided Core Biopsy: Upgrade Rates at Surgical Excision and Implications for Management.

  2021cites this paper
• The lobular neoplasia enigma: management and prognosis in a long follow-up case series

  2021cites this paper
• Non‐invasive lobular neoplasia of the breast: Morphologic features, clinical presentation, and management dilemmas

  2020cites this paper
• Upgrade at excisional biopsy after a core needle biopsy diagnosis of classic lobular carcinoma in situ.

  2020cites this paper
• Risk for Malignant Upgrade After Breast Core Needle Biopsy Diagnosis of Lobular Neoplasia: A Systematic Review and Meta-Analysis.

  2020cites this paper
• Lobular carcinoma in situ: diagnostic criteria and molecular correlates

  2020cites this paper
• Descriptive study comparing outcomes of classic and nonclassic lobular carcinoma in situ (florid and pleomorphic) initially diagnosed on core needle biopsy

  2020influential citation
• Screening vs staging magnetic resonance imaging‐guided core needle breast biopsies: Does MRI indication impact upgrade rate?

  2020cites this paper
• Genetic analysis of pleomorphic and florid lobular carcinoma in situ variants: frequent ERBB2/ERBB3 alterations and clonal relationship to classic lobular carcinoma in situ and invasive lobular carcinoma

  2020cites this paper
• Genomic profiling of pleomorphic and florid lobular carcinoma in situ reveals highly recurrent ERBB2 and ERRB3 alterations

  2020cites this paper
• American registry of pathology expert opinions: The spectrum of lobular carcinoma in situ: Diagnostic features and clinical implications.

  2020cites this paper
• Pleomorphic and Florid Lobular Carcinoma In Situ Variants of the Breast: A Clinicopathologic Study of 85 Cases With and Without Invasive Carcinoma From a Single Academic Center

  2019cites this paper
• Advances in breast cancer treatment

  2019cites this paper
• Breast Cancer Pathology

  2019cites this paper
• Lobular Breast Lesions

  2019cites this paper
• Outcomes of classic lobular neoplasia diagnosed on breast core needle biopsy: a retrospective multi-center study

  2019cites this paper
• Radiology-Pathology Correlation

  2019cites this paper
• Practical Breast Pathology: Frequently Asked Questions

  2019influential citation
• Non-classic LCIS Versus Classic LCIS Versus Atypical Hyperplasia: Should Management be the Same?

  2018cites this paper
• New Thoughts on Atypias of the Breast: Flat Epithelial Atypia, Atypical Ductal Hyperplasia, and Lobular Neoplasia

  2018cites this paper
• Diagnostic Management of the Atypical Hyperplasias: Core Biopsy Alone Versus Excisional Biopsy

  2018cites this paper
• Management of Lobular Neoplasia

  2018cites this paper
• Observation versus excision of lobular neoplasia on core needle biopsy of the breast

  2018cites this paper
• Second International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions)

  2018cites this paper
• Evaluating the Rate of Upgrade to Invasive Breast Cancer and/or Ductal Carcinoma In Situ Following a Core Biopsy Diagnosis of Non-classic Lobular Carcinoma In Situ

  2018cites this paper
• Pathologic Findings of Breast Lesions Detected on Magnetic Resonance Imaging.

  2017cites this paper
• PIK3CA mutations are common in lobular carcinoma in situ, but are not a biomarker of progression

  2017cites this paper
• Lobular Carcinoma In Situ.

  2017cites this paper
• Current Concepts in Diagnosis, Molecular Features, and Management of Lobular Carcinoma In Situ of the Breast With a Discussion of Morphologic Variants.

  2017cites this paper
• Isolated Atypical Lobular Hyperplasia Diagnosed on Breast Biopsy: Low Upgrade Rate on Subsequent Excision With Long-Term Follow-up.

  2017cites this paper
• First International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions)

  2016cites this paper
• than 30 years

  year unknowncites this paper